102 However, several groups are advocating with the incorporation of novel markers, such as a elaborate karyotype55 or epigenetic subsets, 27,28 into clinical follow. All of these novel prognostic and/or predictive models will have to be validated in cohorts of sufferers dealt with with targeted age